---
card_id: scrna-kb-12-enrichment
version: 0.1.0
status: draft
plugin_version: 0.3.0
scientific_reviewer: null
reviewed_on: null
production_rag_eligible: false
---

# Plan enrichment as a future analytical extension

Learning draft. Scientific review is pending.

## Scope

This is a conceptual extension card. GO, KEGG and Reactome enrichment are not implemented by the current plugin. There is no enrichment command to run in the first exercise.

## Principle

Over-representation analysis asks whether a selected gene set contains more genes from an annotated category than expected relative to a defined eligible background. A ranked-list analysis uses a ranking statistic across genes instead of a hard selected-list threshold. They answer related but different questions and need different inputs.

## Decision sequence

1. Define the biological contrast and the gene-selection or ranking rule before inspecting attractive pathways.
2. Verify species and identifiers, document mapping losses and resolve duplicates explicitly.
3. For over-representation, use the genes that could have been selected under the analysis as the background, rather than automatically using every gene in the genome.
4. For ranked analysis, select a defensible signed statistic and an appropriate method; preserve ranking direction and handle ties/missing values explicitly.
5. Record database release, category size filters, method and multiple-testing family. Inspect which genes actually drive each result and whether related terms reuse the same genes.
6. Report association with annotated gene sets. Expression enrichment alone does not establish pathway activation, metabolic flux or a causal mechanism.

## Checks for a future implementation

Before adding an agent tool, validate schema, identifier mapping, reproducibility and sensitivity to plausible background or filtering choices. A new dependency and command need their own tests and explicit output contract. Scientific interpretation must remain separate from whether the enrichment job returned a table.

## Self-check

**Question:** Is a small enrichment p-value proof that a pathway is activated?

**Suggested answer:** No. Inspect contributing genes, direction, annotation context and study design, then seek the functional measurements required for an activation claim.

## Further reading

[Gene Ontology enrichment guidance](https://geneontology.org/docs/go-enrichment-analysis/) explains gene lists and reference/background choices. Consult the selected tool's own method and release documentation before implementation.

## Implementation sources

- [README.md](https://github.com/Sculptor815/scrna-seq-workbench/blob/614917a5c0f678f0894acd3a3a1aa5f9542523de/README.md)

[Learning path](../LEARNING_PATH.md) | [Review worksheet](../REVIEW_WORKSHEET.csv)
